FDA Inspection 1220234 — SpecGx, LLC

SpecGx, LLC — FEI 3005275960

The FDA completed an inspection of SpecGx, LLC on Sep 18, 2023 in Webster Groves, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 18, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Webster Groves, MO (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.